semaglutide for psoriatic arthritis therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes Semaglutide linked to reduced arthritis

PrecisionLife and Ovation are developing a test to predict GLP-1 drug response, enabling precision prescribing and sustainable access to these therapies.

Read Unlocking Long-Term Patient Retention: How Sofwave Bridges the Gap for the GLP-1 Generation to learn about non-invasive ultrasound solutions for wrinkle reduction.

We discuss the use of glucagon-like peptide-1 (GLP-1) analogues as monotherapy and unimolecular dual or triple agonists that exploit the GLP-1 receptor and/or the gastric inhibitory peptide (GIP) receptor and/or the glucagon receptor

Selecting the right patients for GLP-1 therapy and monitoring them closely is key to ensuring safety and optimizing outcomes

Glycosaminoglycan and proteoglycan biosynthesis pathway investigation

7 & 1